Sorafenib and Lenvatinib as first-line treatment of hepatocellular carcinoma: A still controversial comparison.
作者信息
Beenet Linda
机构信息
Department of Pathology & Laboratory Medicine, University of California Los Angeles (UCLA) Technology Center for Genomics & Bioinformatics, Los Angeles, CA, USA.
出版信息
Liver Int. 2021 Jun;41(6):1432. doi: 10.1111/liv.14853. Epub 2021 Apr 19.
PMID:33872444
Abstract
摘要
Zotero 插件